Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,000,655
-$112,043 QoQ
Shares Held
11,815
-7.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.13%
of 13F equity value
Holder Rank
#2,010
of 4,676 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MAGNOLIA CAPITAL ADVISORS LLC holds $19,446,017 across 8 Drug Manufacturers - General names. JNJ ranks #4 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,906 | $5,884,404 | |
| 2 | MRK |
Merck & Co., Inc.
|
34,718 | $4,461,263 | |
| 3 | ABBV |
AbbVie Inc.
|
16,722 | $4,207,924 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
11,815 | $3,000,655 | |
| 5 | AMGN |
Amgen Inc
|
2,427 | $878,865 | |
| 6 | PFE |
Pfizer Inc
|
16,265 | $391,661 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,020 | $381,546 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,160 | $239,699 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,000,655 | 11,815 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,112,698 | 12,734 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,639,647 | 12,755 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,429,002 | 13,100 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,189,671 | 14,335 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $2,316,618 | 13,969 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,929,375 | 13,341 | Shares | Sole | 2025-05-13 | |
| 2024-09-30 | $1,342,991 | 8,287 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $1,137,417 | 7,782 | Shares | Sole | 2024-10-30 | |
| 2023-06-30 | $1,566,646 | 9,465 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,482,265 | 9,563 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,558,936 | 8,825 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,451,126 | 8,883 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,565,815 | 8,821 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,687,052 | 9,519 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,677,854 | 9,808 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $1,551,692 | 9,608 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,456,301 | 8,840 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $395,097 | 2,404 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $249,289 | 1,584 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $235,974 | 1,585 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $218,539 | 1,554 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $205,611 | 1,568 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||